<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Trimebutine (United States: Not available): Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Trimebutine (United States: Not available): Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Trimebutine (United States: Not available): Drug information</div><div class="clear"></div><div id="topicText"><div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
(For additional information <a class="drug drug_patient" data-topicid="12065" href="/d/html/12065.html" rel="external">see "Trimebutine (United States: Not available): Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F231317"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Antispasmodic Agent, Gastrointestinal;</li>
<li>
                        Opioid Agonist, Peripherally-Acting</li></ul></div>
<div class="block doa drugH1Div" id="F231297"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="eba18f55-dd6a-4557-a675-e062b7b7fd7b">Irritable bowel syndrome</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Irritable bowel syndrome (IBS):</b> Oral: 200 mg 3 times/day.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="b25e246e-e906-4ef4-8afe-c037c5857438">Postoperative paralytic ileus</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Postoperative paralytic ileus:</b> Oral: 200 mg 3 times/day.</p></div>
</div>
<p style="text-indent:-2em;margin-left:2em;">
<b>Dosage adjustment for concomitant therapy:</b> Significant drug interactions exist, requiring dose/frequency adjustment or avoidance. Consult drug interactions database for more information.</p></div>
<div class="block dop drugH1Div" id="F231305"><span class="drugH1">Dosing: Pediatric</span>
<p style="text-indent:0em;display:inline">Children ≥12 years and Adolescents: Refer to adult dosing.</p></div>
<div class="block adr drugH1Div" id="F231273"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;">1% to 10%:</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Central nervous system: Mood change (7%), dizziness (≤3%), drowsiness (≤3%), fatigue (≤3%), feeling hot (≤3%), sensation of cold (≤3%), taste disorder (≤3%)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Gastrointestinal: Constipation (≤3%), diarrhea (≤3%), dyspepsia (≤3%), epigastric distress (≤3%), nausea (≤3%), xerostomia (≤3%) </p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Frequency not defined:</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Central nervous system: Anxiety, headache</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Endocrine &amp; metabolic: Gynecomastia, menstrual disease</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Genitourinary: Breast hypertrophy, mastalgia, urinary retention </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Otic: Auditory impairment </p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">&lt;1%, postmarketing, and/or case reports: Skin rash</p></div>
<div class="block coi drugH1Div" id="F231285"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Hypersensitivity to trimebutine or any component of the formulation</p></div>
<div class="block war drugH1Div" id="F231271"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• CNS depression: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).</p></div>
<div class="block prod-avail drugH1Div" id="F11234361"><span class="drugH1">Product Availability</span>
<p style="text-indent:0em;display:inline">Not available in the US</p></div>
<div class="block geq drugH1Div" id="F52885733"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">May be product dependent</p></div>
<div class="block dinfoc drugH1Div" id="F52868513"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Tablet, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 100 mg, 200 mg</p></div>
<div class="block adm drugH1Div" id="F231283"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">Oral: Administer before meals.</p></div>
<div class="block admp drugH1Div" id="F52613975"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Oral: Administer before meals.</p></div>
<div class="block use drugH1Div" id="F231282"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:0em;display:inline">
<b>Note:</b> Not approved in the US</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Irritable bowel syndrome:</b> Treatment and relief of symptoms associated with irritable bowel syndrome (IBS) (spastic colon).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b> Ileus:</b> Treatment of postoperative paralytic ileus in order to accelerate the resumption of the intestinal transit following abdominal surgery</p></div>
<div class="block cyt drugH1Div" id="F13300177"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F231275"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Neuromuscular-Blocking Agents (Nondepolarizing): Trimebutine may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents (Nondepolarizing). <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Sincalide: Drugs that Affect Gallbladder Function may diminish the therapeutic effect of Sincalide.  Management: Consider discontinuing drugs that may affect gallbladder motility prior to the use of sincalide to stimulate gallbladder contraction.<i> Risk D: Consider therapy modification</i></p></div>
<div class="block pri drugH1Div" id="F231287"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;display:inline">Adverse events were not observed in animal reproduction studies. Use in pregnancy is not recommended per the manufacturer. </p></div>
<div class="block dic drugH1Div" id="F231288"><span class="drugH1">Dietary Considerations</span>
<p style="text-indent:0em;display:inline">Should be taken before meals.</p></div>
<div class="block pha drugH1Div" id="F231270"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Spasmolytic agent with antiserotonergic activity and moderate opiate receptor affinity. Reduces abnormal motility; does not alter normal GI motility.</p></div>
<div class="block phk drugH1Div" id="F13228619"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Absorption: Rapid</p>
<p style="text-indent:-2em;margin-left:2em;">Half-life elimination: ~10 to 12 hours</p>
<p style="text-indent:-2em;margin-left:2em;">Time to peak, plasma: Within 1 hour</p>
<p style="text-indent:-2em;margin-left:2em;">Excretion: Urine (primarily); feces (5% to 12%)</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F231289"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AR)</span> <span class="country">Argentina</span><span class="countrySeparator">: </span><span class="drugName">Biorgan | Biorgan ap | Colixane | Conjustron | Debridat | Debridat a.p. | Eumotil | Fenatrop | Fenatrop ap | Miopropan | Miopropan lp | Neotina | Normopax | Normopax 300 AP | Plidex | Plidex AP | Procinet Nf | Relopat | Sangalina | Tributina | Trimebutina | Trimebutina Vannier</span>;</li>
<li>
<span class="countryCode">(BD)</span> <span class="country">Bangladesh</span><span class="countrySeparator">: </span><span class="drugName">Trimotil | Tritin</span>;</li>
<li>
<span class="countryCode">(BF)</span> <span class="country">Burkina Faso</span><span class="countrySeparator">: </span><span class="drugName">Debutine</span>;</li>
<li>
<span class="countryCode">(BG)</span> <span class="country">Bulgaria</span><span class="countrySeparator">: </span><span class="drugName">Tributin</span>;</li>
<li>
<span class="countryCode">(CI)</span> <span class="country">Côte d'Ivoire</span><span class="countrySeparator">: </span><span class="drugName">Colospasmyl | Debridat | Debutine</span>;</li>
<li>
<span class="countryCode">(CL)</span> <span class="country">Chile</span><span class="countrySeparator">: </span><span class="drugName">Debridat | Dolpic | Dolpic forte | Tidomel | Trim | Trimebutino</span>;</li>
<li>
<span class="countryCode">(CN)</span> <span class="country">China</span><span class="countrySeparator">: </span><span class="drugName">Cerekinon | Diway | Nuo wei | Shu li qi neng | Shuang di | Trimebutine | Yuan sheng li wei</span>;</li>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">Antinime | Bi pasmin | Bumetin | Coltrim | Colypan | Debridat | Eumotrix | Fitraless | Isoflav | Kolantil | Kolontil | Lamotris | Lotrel | Muvett | Oclid | Synespas | Tributin | Trimebutina | Trimebutina maleato | Trimesher</span>;</li>
<li>
<span class="countryCode">(DO)</span> <span class="country">Dominican Republic</span><span class="countrySeparator">: </span><span class="drugName">Debridat | Debridat ap | Debrium | Eutransil | Muvett | Polibutin</span>;</li>
<li>
<span class="countryCode">(EC)</span> <span class="country">Ecuador</span><span class="countrySeparator">: </span><span class="drugName">Colypan | Debridat | Dolpic | Eutransil | Gaspat | Muvett | Trimebutina | Trimebutina MK</span>;</li>
<li>
<span class="countryCode">(EG)</span> <span class="country">Egypt</span><span class="countrySeparator">: </span><span class="drugName">Debridat | G Regulator | Gast-reg | Tribudat | Trigenda | Tritone</span>;</li>
<li>
<span class="countryCode">(ES)</span> <span class="country">Spain</span><span class="countrySeparator">: </span><span class="drugName">Polibutin</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">Debricalm | Debridat | Modulon | Transacalm | Trimebutine | Trimebutine Actavis | Trimebutine Almus | Trimebutine Alter | Trimebutine arrow | Trimebutine biogaran | Trimebutine Cristers | Trimebutine evolugen | Trimebutine g gam | Trimebutine gerda | Trimebutine gnr | Trimebutine irex | Trimebutine Isomed | Trimebutine ivax | Trimebutine merck | Trimebutine Pfizer | Trimebutine Qualimed | Trimebutine Ratiopharm | Trimebutine Rpg | Trimebutine Sandoz | Trimebutine teva | Trimebutine zydus</span>;</li>
<li>
<span class="countryCode">(GR)</span> <span class="country">Greece</span><span class="countrySeparator">: </span><span class="drugName">Ibutin</span>;</li>
<li>
<span class="countryCode">(HK)</span> <span class="country">Hong Kong</span><span class="countrySeparator">: </span><span class="drugName">Cerekinon | Scd trimebutine | Tritin</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">Trimspa</span>;</li>
<li>
<span class="countryCode">(JP)</span> <span class="country">Japan</span><span class="countrySeparator">: </span><span class="drugName">Behm | Butikinon | Celvel | Cerekinon | Coolbutin | Gastlock | Isutinon iwaki | Isutinon teisan | Liement | Liement chemiphar | Malebutine | Mebucolon | Mebutit | Meptart | Movarol | Mustrick | Naruhiton | Nepten | Nichimalon | Pelkysil | Pilemain | Sakion | Sakion hexal | Sakion kayaku | Salnatin | Selumito | Supeslone | Tefmetin | Trasben | Trikinosin | Trishi ohara</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Aerin ssuk | Anitine | Anytine | Anytinin | Bebutin | Benznal | Bimetin | Boryung trimebutine maleate | Butimerin | Celltrion trimebutine maleate | Cerekinon | Crobutin | Crobutine | Ctmetine | Elbutine | Embutin | Genuone trimebutine maleate | Hanabutin | Huniz trimebutine maleate | Ilyangbio trimebutine maleate | J butine | Jesbutine | Jintroi | Jintroy f | Juni | L butine | Mabin | Mabutan | Malbuthin | Maldive | Malebutine | Malix | Manpotin | Maributin | Mebulatin | Meburan | Mebut | Mebutin | Mekospasm | Meritin | Meriton Sr | Mirae trimebutine | Motric | Mributin | Mybutin | Mybutine | Neobutin sr | Newbutin sr | Pobutin | Polybutin | Polybutin s.r | Polybutine | Probutine | Recutin | Rimebutin | Rimex | Sambutin | Samchundang trimebutine | Sammetin | Sinbutin | Sinil trimebutine maleate | Spabutin | Talributine | Tambutine | Tarabutin | Tialbutin | Timebutin | Timetin | Tokarus | Toles | Tores | Torhes | Tri m | Tributin | Tributin sr | Tricool | Triel | Trien | Trima | Trimebutine | Trimebutine maleate hanall | Trimen | Trimetine | Trione | Trissak | Withus trimebutine maleate | Yumebutine</span>;</li>
<li>
<span class="countryCode">(LB)</span> <span class="country">Lebanon</span><span class="countrySeparator">: </span><span class="drugName">Debritine | Debutine</span>;</li>
<li>
<span class="countryCode">(LV)</span> <span class="country">Latvia</span><span class="countrySeparator">: </span><span class="drugName">Neobutin</span>;</li>
<li>
<span class="countryCode">(MA)</span> <span class="country">Morocco</span><span class="countrySeparator">: </span><span class="drugName">Debridat | Inductan</span>;</li>
<li>
<span class="countryCode">(MX)</span> <span class="country">Mexico</span><span class="countrySeparator">: </span><span class="drugName">Apocol | Cineprac | Crismotil | Debridat | Dolbutin | Espabion | Libertrim | Libertrim lp | Prescol | Scitin | Tempolib | Trimebutina</span>;</li>
<li>
<span class="countryCode">(MY)</span> <span class="country">Malaysia</span><span class="countrySeparator">: </span><span class="drugName">Cerekinon | Debridat</span>;</li>
<li>
<span class="countryCode">(NO)</span> <span class="country">Norway</span><span class="countrySeparator">: </span><span class="drugName">Debridat</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Colonix | Crolipsa | Debridat | Debridat ap | Muvett | Muvett sm | Neucinet s | Trimebutina genfar | Trimet</span>;</li>
<li>
<span class="countryCode">(PK)</span> <span class="country">Pakistan</span><span class="countrySeparator">: </span><span class="drugName">Debridat | Tribate | Trimin</span>;</li>
<li>
<span class="countryCode">(PL)</span> <span class="country">Poland</span><span class="countrySeparator">: </span><span class="drugName">Debretin | Debridat | Ircolon | Ircolon gastro | Tribux | Tribux bio</span>;</li>
<li>
<span class="countryCode">(PT)</span> <span class="country">Portugal</span><span class="countrySeparator">: </span><span class="drugName">Debridat</span>;</li>
<li>
<span class="countryCode">(PY)</span> <span class="country">Paraguay</span><span class="countrySeparator">: </span><span class="drugName">Distonil | Eumotrix | Eumotrix retard | Orudis | Trimebutina indufar | Trimebutina maleato | Ulcepina</span>;</li>
<li>
<span class="countryCode">(RO)</span> <span class="country">Romania</span><span class="countrySeparator">: </span><span class="drugName">Colobutine | Colperin | Debridat | Ibutin | Trimebutin</span>;</li>
<li>
<span class="countryCode">(RU)</span> <span class="country">Russian Federation</span><span class="countrySeparator">: </span><span class="drugName">Debridat | Neobutin | Neobutin retard | Trimebutine sz | Trimedat | Trimedat forte</span>;</li>
<li>
<span class="countryCode">(SG)</span> <span class="country">Singapore</span><span class="countrySeparator">: </span><span class="drugName">Cerekinon | Debridat</span>;</li>
<li>
<span class="countryCode">(TH)</span> <span class="country">Thailand</span><span class="countrySeparator">: </span><span class="drugName">Cerekinon | Debridat</span>;</li>
<li>
<span class="countryCode">(TN)</span> <span class="country">Tunisia</span><span class="countrySeparator">: </span><span class="drugName">Colospasmyl | Debricol | Debridat | Transacalm | Trimebutine | Trimegam</span>;</li>
<li>
<span class="countryCode">(TR)</span> <span class="country">Turkey</span><span class="countrySeparator">: </span><span class="drugName">Debridat | Debrutin fort | Gismotal | Tirebrant | Tribudat</span>;</li>
<li>
<span class="countryCode">(TW)</span> <span class="country">Taiwan</span><span class="countrySeparator">: </span><span class="drugName">Trimetin</span>;</li>
<li>
<span class="countryCode">(UA)</span> <span class="country">Ukraine</span><span class="countrySeparator">: </span><span class="drugName">Trimspa</span>;</li>
<li>
<span class="countryCode">(UY)</span> <span class="country">Uruguay</span><span class="countrySeparator">: </span><span class="drugName">Aldar | Eumotil</span>;</li>
<li>
<span class="countryCode">(VE)</span> <span class="country">Venezuela, Bolivarian Republic of</span><span class="countrySeparator">: </span><span class="drugName">Bumetin | Colypan | Dobracid | Muvett | Trimbet | Trimebutina | Trimebutina maleato</span>;</li>
<li>
<span class="countryCode">(VN)</span> <span class="country">Viet Nam</span><span class="countrySeparator">: </span><span class="drugName">Agitritine | Butridat | Debutinat | Hasanbin | Iboten | Newbutin sr</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference">
                  Modulon (trimebutine) [product monograph]. Mont-Saint-Hilaire, Quebec, Canada: Aptalis Pharma Canada Inc; November 2011.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Trimebutine.1">
<a name="Trimebutine.1"></a>MINT-Trimebutine (trimebutine maleate) [product monograph]. Mississauga, Ontario, Canada: Mint Pharmaceuticals Inc; May 2023.</div>
</li></ol></div><div id="topicVersionRevision">Topic 10111 Version 95.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
